Mexico City, November 7, 2026 — Canaritech, the Mexican contract research organization (CRO) specializing in comprehensive solutions for the health industry, announces the launch of a new service line designed to help Mexican entrepreneurs and companies develop dietary supplements and cosmetic products to world-class standards and export them to the U.S. market without regulatory friction.
The new service combines scientific and technical formulation development with end-to-end regulatory support, ensuring simultaneous compliance with Mexico’s Federal Commission for the Protection against Sanitary Risk (Cofepris) and the U.S. Food and Drug Administration (FDA).
A Regulatory Bridge Between Mexico and the United States
For a Mexican supplement or cosmetic to reach U.S. shelves, a good product alone is not enough. Companies must obtain the Export Support Certificate issued by Cofepris, a document certifying that products comply with current sanitary legislation and that is essential for exporting dietary supplements and cosmetics.
On the U.S. side, the regulatory landscape requires a different strategy depending on the product category. While cosmetics do not require prior FDA approval before marketing, since July 2024 the Modernization of Cosmetics Regulation Act (MoCRA) has made facility registration and product and ingredient listing mandatory. For dietary supplements, the FDA requires compliance with current Good Manufacturing Practices (cGMP), facility registration, prior notice of importation, and verification of the foreign supplier (FSVP).
“Many Mexican entrepreneurs have extraordinary products, but they get lost in the maze of procedures and technical requirements on both sides of the border. Our program was created so they can focus on their brand and their customers while we make sure every formula, every label, and every dossier complies with Cofepris and the FDA,” said Francisco Javier Pérez Davó, CEO of Canaritech.
A Program Designed for Entrepreneurs
Canaritech structures this service as an entrepreneur support program, with a phased model that adapts to different budgets and development timelines:
Regulatory diagnosis and feasibility: assessment of the product category (supplement vs. cosmetic) and an export roadmap.
Development and formulation: scientific and technical support to adjust the formula to FDA-accepted labeling requirements, permitted ingredients, and claims.
Documentation and filings: preparation of the dossier for Cofepris’s Export Certificate, FDA facility registration (MoCRA for cosmetics), and appointment of a U.S. legal agent when applicable.
Import readiness: guidance on prior notice, FSVP, and cGMP compliance for supplements.
About Canaritech
Canaritech is a contract research organization (CRO) with a presence in Latin America, dedicated to providing comprehensive solutions for clinical trials and health product development. Its team combines scientific, regulatory, and legal expertise to support companies and entrepreneurs from product conception to market entry.
